Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4542795 | 5698912 | F | 4542795-2 | 20040810 | 20041213 | 20041231 | EXP | PHBS2004JP16713 | NOVARTIS PHARMACEUTICALS CORP. | 55 | YR | M | Y | 20041231 | MD |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4542795 | 1005547067 | PS | DIOVAN | 1 | ORAL | 80 MG/DAY | |||||
| 4542795 | 1005547068 | C | ZEFFIX | 2 | ORAL | 100 MG, UNK |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 4542795 | 1005547067 | HYPERTENSION |
| 4542795 | 1005547068 | HEPATITIS B |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 4542795 | HO |
Reactions reported
| Event ID | PT |
|---|---|
| 4542795 | ALANINE AMINOTRANSFERASE INCREASED |
| 4542795 | ASPARTATE AMINOTRANSFERASE INCREASED |
| 4542795 | CONDITION AGGRAVATED |
| 4542795 | HEPATIC FUNCTION ABNORMAL |
| 4542795 | HEPATITIS B |
| 4542795 | LYMPHOCYTE STIMULATION TEST POSITIVE |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 4542795 | 1005547067 | 20040713 | 20040913 | 90720 | MIN |
| 4542795 | 1005547068 | 20030301 |